Page last updated: 2024-08-23

phenyl acetate and Prostatic Neoplasms, Castration-Resistant

phenyl acetate has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blomqvist, L; Farnebo, J; Jacobsson, H; Nilsson, S; Sandström, P; Ullén, A; Wadelius, A	1

Other Studies

1 other study(ies) available for phenyl acetate and Prostatic Neoplasms, Castration-Resistant

Article	Year
Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT. Medicine, 2016, Volume: 95, Issue:31 Topics: Abiraterone Acetate; Acetates; Administration, Oral; Aged; Antineoplastic Agents; Carbon; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Analysis; Treatment Outcome	2016

Article

Year

Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.

Medicine, 2016, Volume: 95, Issue:31

Topics: Abiraterone Acetate; Acetates; Administration, Oral; Aged; Antineoplastic Agents; Carbon; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Analysis; Treatment Outcome

2016